Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria.

In this episode:
Approved indication and PBS clinical criteria for finerenone
Safety profile and benefits of finerenone for type 2 diabetes patients with CKD
Initiation, dosing and titration process
What this treatment means for GPs and their type 2 diabetes patients with CKD

<p>Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria.</p>
<p>In this episode:</p>
<ul>
<li>Approved indication and PBS clinical criteria for finerenone</li>
<li>Safety profile and benefits of finerenone for type 2 diabetes patients with CKD</li>
<li>Initiation, dosing and titration process</li>
<li>What this treatment means for GPs and their type 2 diabetes patients with CKD</li>
</ul>

Healthed's medical education channel features the latest high quality clinical interviews and lectures from leading experts in their field, offering health professionals a convenient new way to boost their knowledge.

Advertisement